Global Fungal Keratitis Treatment Market Share

Market Share of Global Fungal Keratitis Treatment Industry

The Fungal Keratitis Treatment Market is moderately competitive. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Pfizer Inc., Leadiant Biosciences, Gilead Biosciences, Inc., Bausch Health, Novo Holdings A/S (Xellia Pharmaceuticals), Alvogen, and Merck & Co. Inc. The companies are evolving through various strategies such as mergers and acquisitions, collaborations, and partnerships, along with investment in research and development activities to secure the position in the competitive market. For instance, in October 2019, Eyevance Pharmaceuticals announced the acquisition of TOBRADEX ST (tobramycin/dexamethasone ophthalmic suspension) 0.3%/0.05% and NATACYN (natamycin ophthalmic suspension) 5% from Novartis.

Fungal Keratitis Treatment Market Leaders

1. Merck & Co. Inc.

2. Bausch Health

3. Gilead Biosciences

4. Pfizer Inc.

5. Glenmark Pharmaceuticals

*Disclaimer: Major Players sorted in no particular order